Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
7.04
-0.04 (-0.56%)
At close: Feb 2, 2026, 4:00 PM EST
6.90
-0.14 (-1.99%)
After-hours: Feb 2, 2026, 7:48 PM EST
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $377.25 million as of February 2, 2026. Its market cap has increased by 68.18% in one year.
Market Cap
377.25M
Enterprise Value
245.14M
1-Year Change
68.18%
Ranking
Category
Stock Price
$7.04
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $377.25M, an increase of 117.86%. That is a compound annual growth rate of 13.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 377.25M | 32.08% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 403.49M |
| Adlai Nortye | 392.25M |
| NovaBridge Biosciences | 381.61M |
| Aclaris Therapeutics | 380.29M |
| Rocket Pharmaceuticals | 376.61M |
| Enanta Pharmaceuticals | 374.34M |
| Tectonic Therapeutic | 374.14M |
| Zura Bio | 369.33M |